Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients

BACKGROUND. Bevacizumab leads to improved survival for patients with metastatic colorectal cancer (CRC) or non-small cell lung cancer (NSCLC) when added to chemotherapy. Little is known about factors associated with receipt of bevacizumab, or whether bevacizamab is associated with increased toxicity...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Mohile, Supriya G., Hardt, Molly, Tew, William, Owusu, Cynthia, Klepin, Heidi, Gross, Cary, Gajra, Ajeet, Lichtman, Stuart M., Feng, Tao, Togawa, Kayo, Ramani, Rupal, Katheria, Vani, Hansen, Kurt, Hurria, Arti
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2013
Teme:
Geriatric Oncology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3639527/
https://ncbi.nlm.nih.gov/pubmed/23576485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0351
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items